Northstar Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,276
Closed -$407K 88
2021
Q2
$407K Buy
3,276
+426
+15% +$53.5K 0.25% 69
2021
Q1
$337K Buy
2,850
+70
+3% +$8.2K 0.26% 71
2020
Q4
$326K Buy
+2,780
New +$306K 0.27% 73

Other funds holding MDT

Northstar Advisory Group's MDT Position: Q3 2021 in Review

Northstar Advisory Group sold out of Medtronic (MDT) in Q3 2021, closing a stake of 3,276 shares — an estimated $407K sold.

Northstar Advisory Group first reported a position in MDT in Q4 2020 and held it in 3 quarters. The position peaked at $407K in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Northstar Advisory Group reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Northstar Advisory Group sold 3,276 Medtronic shares in Q3 2021, an estimated $407K.
  • Northstar Advisory Group first reported a position in Medtronic in Q4 2020 and held it in 3 quarters.
  • Northstar Advisory Group's Medtronic position peaked at $407K in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Northstar Advisory Group's 13F filing for Q3 2021, filed 14 Oct 2021.